Form 4: Haemonetics Corp: Executive Sells Shares for Tax Withholding
Insider Transaction Filing
Haemonetics Corp reports a transaction where VP, Chief Accounting Officer Maryanne Farris sold shares to cover tax obligations related to vested RSUs.
Summary
- Maryanne Farris, VP, Chief Accounting Officer of Haemonetics Corp, engaged in a transaction on June 5, 2026.
- The transaction involved the disposal of 259 shares of common stock.
- These shares were withheld to cover tax obligations arising from the vesting of restricted stock units (RSUs).
- The sale price for these shares was $71.28 per share.
- Following this transaction, Farris beneficially owns 6,242 shares of common stock.
- This ownership figure includes unvested RSUs.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transaction is a standard procedure for tax compliance related to executive compensation and does not reflect a change in the executive's fundamental view of the company's prospects.
Negatives
- A portion of the executive's vested equity compensation was sold to cover taxes, indicating a cash outflow for tax purposes.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it pertains to an insider transaction for tax purposes.
Industry Context
StockSavvy.ai notes that insider transactions for tax withholding are common events, particularly with the vesting of equity compensation. This specific transaction for Haemonetics Corp (HAE) is a routine event for executives managing their compensation and tax liabilities.
Stakeholder Impact
- Shareholders: No direct impact on the company's operations or financial health. The transaction is between an executive and the tax authorities.
- Employees: No direct impact, as this is an individual executive compensation and tax matter.
- Management: Reflects standard compensation and tax management practices for senior executives.
Key Dates
| Date | Description |
|---|---|
| 06/05/2026 | Transaction date for the sale of shares to cover tax obligations. |
| 06/08/2026 | Date of the signature on the filing. |
Keywords
Haemonetics Corp, HAE, Form 4, Insider Transaction, Stock Sale, Tax Withholding, RSU Vesting, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.